JP2009503097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503097A5 JP2009503097A5 JP2008525163A JP2008525163A JP2009503097A5 JP 2009503097 A5 JP2009503097 A5 JP 2009503097A5 JP 2008525163 A JP2008525163 A JP 2008525163A JP 2008525163 A JP2008525163 A JP 2008525163A JP 2009503097 A5 JP2009503097 A5 JP 2009503097A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- disease
- prednisolone acetate
- prednisolone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70537005P | 2005-08-04 | 2005-08-04 | |
| PCT/US2006/030140 WO2007019184A2 (en) | 2005-08-04 | 2006-08-03 | Oral suspension of prednisolone acetate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012236009A Division JP2013014634A (ja) | 2005-08-04 | 2012-10-25 | 酢酸プレドニゾロンの経口懸濁液 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009503097A JP2009503097A (ja) | 2009-01-29 |
| JP2009503097A5 true JP2009503097A5 (https=) | 2009-09-17 |
Family
ID=37727875
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525163A Pending JP2009503097A (ja) | 2005-08-04 | 2006-08-03 | 酢酸プレドニゾロンの経口懸濁液 |
| JP2012236009A Abandoned JP2013014634A (ja) | 2005-08-04 | 2012-10-25 | 酢酸プレドニゾロンの経口懸濁液 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012236009A Abandoned JP2013014634A (ja) | 2005-08-04 | 2012-10-25 | 酢酸プレドニゾロンの経口懸濁液 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7799331B2 (https=) |
| EP (2) | EP2630951A1 (https=) |
| JP (2) | JP2009503097A (https=) |
| KR (1) | KR20080044245A (https=) |
| CN (1) | CN101247786A (https=) |
| AU (1) | AU2006278620B2 (https=) |
| CA (1) | CA2616112A1 (https=) |
| IL (1) | IL189257A0 (https=) |
| NZ (1) | NZ566117A (https=) |
| WO (1) | WO2007019184A2 (https=) |
| ZA (1) | ZA200800926B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799331B2 (en) * | 2005-08-04 | 2010-09-21 | Taro Pharmaceutical North America, Inc. | Oral suspension of prednisolone acetate |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| EP2001442A4 (en) * | 2006-04-06 | 2013-10-23 | Taro Pharmaceuticals North America Inc | NOVEL EXPERIMENTAL FORMULATIONS WITH HYDROCOLLOIDAL POLYMERS |
| EP2197416A1 (en) * | 2007-10-09 | 2010-06-23 | Novartis Ag | Pharmaceutical formulation of valsartan |
| US20090143343A1 (en) * | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| EP2214679B1 (en) | 2007-11-13 | 2019-03-27 | Meritage Pharma, Inc. | Corticosteroid compositions |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| ES2811051T3 (es) * | 2008-08-20 | 2021-03-10 | Univ California | Corticosteroides para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal |
| US20110097401A1 (en) * | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| JP6694525B2 (ja) * | 2016-05-06 | 2020-05-13 | ハーロウ・ヘルス・インコーポレイテッドＨａｒｒｏｗ Ｈｅａｌｔｈ， Ｉｎｃ． | 薬学的眼病用組成物およびそれを製造するための方法 |
| EP3509572A4 (en) * | 2016-09-08 | 2020-05-13 | Synergistic Therapeutics, LLC | TOPICAL FORMULATION FOR HAIR GROWTH |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4265823A (en) * | 1979-01-04 | 1981-05-05 | Robert E. Kosinski | Aurothiosteroids |
| US4448774A (en) | 1982-12-22 | 1984-05-15 | Fisons Corporation | Steroid formulation |
| US5145675A (en) * | 1986-03-31 | 1992-09-08 | Advanced Polymer Systems, Inc. | Two step method for preparation of controlled release formulations |
| CA2138957A1 (en) * | 1992-07-30 | 1994-02-17 | Shigeki Omura | A remedy for inflammatory intestinal diseases |
| IL108366A (en) | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
| US5881926A (en) | 1993-03-11 | 1999-03-16 | Taro Pharmaceutical Industries, Ltd. | Pharmaceutical compositions in semisolid form and a device for administration thereof |
| US20030203976A1 (en) * | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
| US5480914A (en) | 1994-05-06 | 1996-01-02 | Allergan, Inc. | Nonaqueous thixotropic drug delivery suspensions and methods of their use |
| US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| US5763449A (en) * | 1996-08-07 | 1998-06-09 | Ascent Pediatrics, Inc. | Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| US6071523A (en) | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
| AU757896B2 (en) * | 1998-09-02 | 2003-03-13 | Allergan, Inc. | Preserved cyclodextrin-containing compositions |
| US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
| WO2002058662A2 (en) * | 2001-01-24 | 2002-08-01 | Oraceutical Llc | Topical oral care compositions |
| ATE502642T1 (de) | 2001-10-05 | 2011-04-15 | Zalicus Inc | Kombinationen für die behandlung von immun- entzündlichen erkrankungen |
| US7001615B1 (en) | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
| WO2003049745A1 (en) | 2001-12-12 | 2003-06-19 | Pharmacia Corporation | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| AU2003238221A1 (en) | 2002-06-17 | 2003-12-31 | Taro Pharmaceuticals U.S.A, Inc. | Ibuprofen suspension |
| EP1658083B1 (en) * | 2003-06-19 | 2007-08-08 | BODOR, Nicholas S. | Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| CA2550811C (en) | 2003-12-24 | 2012-05-01 | Jane Hirsh | Temperature-stable formulations, and methods of development thereof |
| EP1744760B1 (en) * | 2004-04-22 | 2015-01-07 | AcuCort AB | Pharmaceutical compositions for acute glucocorticoid therapy |
| US6969706B1 (en) * | 2004-05-12 | 2005-11-29 | Allergan, Inc. | Preserved pharmaceutical compositions comprising cyclodextrins |
| US7799331B2 (en) | 2005-08-04 | 2010-09-21 | Taro Pharmaceutical North America, Inc. | Oral suspension of prednisolone acetate |
-
2006
- 2006-07-13 US US11/457,197 patent/US7799331B2/en active Active
- 2006-08-03 NZ NZ566117A patent/NZ566117A/en not_active IP Right Cessation
- 2006-08-03 WO PCT/US2006/030140 patent/WO2007019184A2/en not_active Ceased
- 2006-08-03 AU AU2006278620A patent/AU2006278620B2/en not_active Ceased
- 2006-08-03 CA CA002616112A patent/CA2616112A1/en not_active Abandoned
- 2006-08-03 JP JP2008525163A patent/JP2009503097A/ja active Pending
- 2006-08-03 EP EP13169273.3A patent/EP2630951A1/en not_active Withdrawn
- 2006-08-03 CN CNA2006800290686A patent/CN101247786A/zh active Pending
- 2006-08-03 EP EP06789228A patent/EP1909798A4/en not_active Withdrawn
- 2006-08-03 KR KR1020087003972A patent/KR20080044245A/ko not_active Abandoned
-
2008
- 2008-01-29 ZA ZA2008/00926A patent/ZA200800926B/en unknown
- 2008-02-04 IL IL189257A patent/IL189257A0/en unknown
-
2010
- 2010-08-27 US US12/870,144 patent/US8206727B2/en active Active
-
2012
- 2012-05-30 US US13/483,273 patent/US8461139B2/en not_active Expired - Fee Related
- 2012-10-25 JP JP2012236009A patent/JP2013014634A/ja not_active Abandoned
-
2013
- 2013-02-01 US US13/756,731 patent/US20130143853A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2742525T3 (es) | Composiciones de corticosteroides administradas oralmente | |
| JP2009503097A5 (https=) | ||
| ES2339790T3 (es) | Efecto neuroprotector de udca solubilizado en modelo isquemico focal. | |
| ES2658166T3 (es) | Producto para administración oral | |
| US8840924B2 (en) | Compositions and methods of making rapidly dissolving ionically masked formulations | |
| ES2462536T3 (es) | Comprimido orodispersable multicapa | |
| JP5841151B2 (ja) | 鼻腔噴霧剤 | |
| ES3027652T3 (en) | Orally inhaled and nasal benzodiazepines | |
| KR20150011807A (ko) | 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물 | |
| ES2624585T3 (es) | Sistema de suministro de compuesto terapéutico oral | |
| TWI343263B (en) | Patches for mucosa of oral cavity containing fentanyl | |
| Behra et al. | An exhaustive review on recent advancement in pharmaceutical bioadhesive used for systemic drug delivery through oral mucosa for achieving maximum pharmacological response and effect | |
| ES2266288T3 (es) | Pulverizador nasal tixotropico. | |
| EP4076381B1 (en) | Transmucosal therapeutic system containing agomelatine | |
| ES2272689T3 (es) | Dihidro-triterpenos en el tratamiento de infecciones virales, enfermedad cardiovascular, inflamacion, hipersensibilidad o dolor. | |
| JP2005518435A5 (https=) | ||
| Patel et al. | Mucoadhesive buccal drug delivery system. | |
| EP3704123A1 (en) | Hydrophobic acid addition salts and pharmaceutical formulations thereof | |
| JP5828007B2 (ja) | 局所投与型の嚥下障害改善用医薬品 | |
| ES2507570T3 (es) | Terapia de combinación de Zn/trimetoprim | |
| WO2011064769A1 (en) | Methods and pharmaceutical compositions for the treatment of hot flashes | |
| ES2746951T3 (es) | Suspensión oral para tratar esofagitis eosinofílica | |
| CN101842318A (zh) | 用于治疗和预防呼吸疾病或病症的甘油磷酸钙 | |
| KR100807480B1 (ko) | 피리베딜의 경비 투여용 약제 조성물 | |
| ES2399053T3 (es) | Composiciones para administración intranasal |